ONB
BMRN icon

Old National Bancorp’s BioMarin Pharmaceuticals BMRN Stock Holding History

Old National Bancorp’s Portfolio BMRN Stock Details BMRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-1,857
Closed -$231K – 635
2015
Q1 		$231K Buy
+1,857
New +$197K 0.01% 559

Other funds holding BMRN

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Old National Bancorp's BMRN Position: Q2 2015 in Review

Old National Bancorp sold out of BioMarin Pharmaceuticals (BMRN) in Q2 2015, closing a stake of 1,857 shares — an estimated $231K sold.

Old National Bancorp first reported a position in BMRN in Q1 2015 and held it in 1 quarter. The position peaked at $231K in Q1 2015. 391 funds tracked by Wall St. Rank hold BMRN as of Q2 2015.

  • Old National Bancorp reported no remaining BioMarin Pharmaceuticals position as of Q2 2015 after selling out during the quarter.
  • Old National Bancorp sold 1,857 BioMarin Pharmaceuticals shares in Q2 2015, an estimated $231K.
  • Old National Bancorp first reported a position in BioMarin Pharmaceuticals in Q1 2015 and held it in 1 quarter.
  • Old National Bancorp's BioMarin Pharmaceuticals position peaked at $231K in Q1 2015.
  • 391 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q2 2015.

Based on Old National Bancorp's 13F filing for Q2 2015, filed 17 Aug 2015.